Výsledky vyhledávání - "S C, Patiño"

How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain

Autor: A, Castañeda, M, Gorostegui, S L, Miralles, A, Chamizo, S C, Patiño, M A, Flores, M, Garraus, J J, Lazaro, V, Santa-Maria, A, Varo, J P, Muñoz, J, Mora

Publikováno v: ESMO Open. 7:100462

Naxitamab [humanized 3f8 (hu3F8)] is a humanized monoclonal antibody (mAb) targeting the disialoganglioside GD2. It was approved in 2020 by the United States Food and Drug Administration (FDA) in combination with granulocyte-macrophage colony-stimula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24aa9c9049bc9706a2571b0af9d2c282
https://doi.org/10.1016/j.esmoop.2022.100462

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání